Two Sigma Advisers’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-12,000
| Closed | -$9K | – | 3009 |
|
|
2022
Q1 | $9K | Sell |
12,000
-49,400
| -80% | -$37.1K | ﹤0.01% | 2701 |
|
|
2021
Q4 | $61K | Sell |
61,400
-35,700
| -37% | -$35.5K | ﹤0.01% | 2461 |
|
|
2021
Q3 | $170K | Sell |
97,100
-56,186
| -37% | -$98.4K | ﹤0.01% | 2278 |
|
|
2021
Q2 | $281K | Buy |
153,286
+25,786
| +20% | +$47.3K | ﹤0.01% | 2159 |
|
|
2021
Q1 | $258K | Buy |
127,500
+50,000
| +65% | +$101K | ﹤0.01% | 2277 |
|
|
2020
Q4 | $167K | Buy |
77,500
+36,500
| +89% | +$78.7K | ﹤0.01% | 2205 |
|
|
2020
Q3 | $111K | Buy |
+41,000
| New | +$111K | ﹤0.01% | 2263 |
|
|
2016
Q2 | – | Sell |
-760
| Closed | -$14K | – | 2263 |
|
|
2016
Q1 | $14K | Buy |
760
+30
| +4% | +$553 | ﹤0.01% | 2011 |
|
|
2015
Q4 | $19K | Sell |
730
-385
| -35% | -$10K | ﹤0.01% | 1844 |
|
|
2015
Q3 | $51K | Buy |
1,115
+530
| +91% | +$24.2K | ﹤0.01% | 1762 |
|
|
2015
Q2 | $19K | Hold |
585
| – | – | ﹤0.01% | 1854 |
|
|
2015
Q1 | $19K | Buy |
+585
| New | +$19K | ﹤0.01% | 1835 |
|